Severe COPD is often fatal, but long-term treatment with supplemental oxygen improves survival in patients with COPD and severe resting hypoxemia. However, it is not known if long-term oxygen prolongs life in those with less-than-severe hypoxemia. Given the paucity of alternative treatments, many physicians prescribe oxygen for patients with severe COPD even when their hypoxemia is not reproducibly severe, despite the lack of a scientific basis for this practice.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
NIH Inter-Agency Agreements (Y01)
Project #
AHL12029001-1-0-1
Application #
8567705
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$22,025
Indirect Cost
Name
National Heart, Lung, and Blood Institute
Department
Type
DUNS #
City
State
Country
Zip Code